# Repurposing Semaglutide for the Treatment of Cocaine Use Disorder

> **NCT07227948** · PHASE2 · RECRUITING · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 75 (estimated)

## Conditions studied

- Cocaine Use Disorder

## Interventions

- **DRUG:** Semaglutide
- **DRUG:** Placebo
- **BEHAVIORAL:** cognitive behavioral therapy (CBT).

## Key facts

- **NCT ID:** NCT07227948
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2029-01-28
- **Final completion:** 2029-02-28
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07227948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07227948, "Repurposing Semaglutide for the Treatment of Cocaine Use Disorder". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07227948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*